Downregulation of cell cycle-associated transcriptional signatures was associated with a marked up-regulation of the tumor suppressor CDKN2A (encoding the negative cell-cycle regulator P16INK4a-ARF), which is commonly mutated in B-ALL (Fig. 3h). The gene discussed is CDKN2A; the disease is precursor B-cell acute lymphoblastic leukemia.